RA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
RA PHARMACEUTICALS, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$12.00 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-05-11
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$12.00M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$9.02M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-03-31 was -$5.65M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-12-31 was -$3.20M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$21.84M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$12.02M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$7.55M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$12.00M 10-Q · filed 2017-05-11 | -$21.02M derived: sum of 2 quarters · filed 2017-05-11 | ||
| 2016-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$21.84M 10-K · filed 2017-03-06 | ||
| 2016-09-30 | -$12.82M 10-Q · filed 2016-11-29 | |||
| 2016-03-31 | -$5.65M 10-Q · filed 2017-05-11 | -$8.85M derived: sum of 2 quarters · filed 2017-05-11 | ||
| 2015-12-31 | -$3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$12.02M 10-K · filed 2017-03-06 | ||
| 2015-09-30 | -$8.81M 10-Q · filed 2016-11-29 | |||
| 2014-12-31 | -$7.55M 10-K · filed 2017-03-06 |